Association of no syntase inhibitors with trappers of oxygen reactive forms
AssigneeSociete de Conseils de Recherches et d'Applications Scientifiques (S.C.R.A.S.)
InventorsPierre-Etienne Chabrier de Lassauniere, Dennis Bigg
Life of this patent
Estimating the term…
Abstract
The invention concerns a pharmaceutical composition containing, as active principle, at least one NO syntase inhibiting substance and at least one oxygen reactive form trapping substance, optionally with a pharmaceutically acceptable support. The invention also concerns a product containing at least one NO syntase inhibiting substance and at least one oxygen reactive form trapping substance as combined product of these active principles in separate form.
Claims4
A pharmaceutical composition comprising at least one substance inhibiting NO synthase selected from the group consisting of aminoguanidine, nitroarginine and nitroimidazole, and 3,5-ditert-butyl-4-hydroxy-benzoic acid which traps reactive forms of oxygen.
Dependencies are inferred from the claim text.